Medtronic announced two new milestones for its Affera Sphere-360 catheter for pulsed field ablation (PFA) procedures.

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced two major milestones for the Affera™ ...

The FDA approved the first pulsed field ablation (PFA) catheter, the PulseSelect PFA system, for the treatment of paroxysmal and persistent atrial fibrillation (Afib), Medtronic announced on Wednesday ...

Medtronic’s Affera Sphere-360 is a single-shot device, putting it in direct competition with Boston Scientific’s Farawave ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted a new indication to a cryoballoon ablation catheter that allows it to be used as a first-line ...

About LockeT Catheter Precision’s LockeT is a suture retention device intended to assist in wound closure after percutaneous venous punctures. LockeT is a Class 1 device registered with the FDA and ...

First-line treatment with catheter ablation is superior to drug therapy for reducing atrial fibrillation, according to five year results from the MANTRA-PAF trial presented for the first time at ESC ...

CHICAGO, IL—For patients with ischemic cardiomyopathy and ventricular tachycardia (VT) who have an implantable cardioverter-defibrillator (ICD), catheter ablation may be a better first-line therapy ...

Catheter Precision, Inc. has announced its first purchase order for the VIVO product from Sahlgrenska University Hospital in Sweden, which is the largest hospital in the country and has a substantial ...